Erik Harris is EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc.
Person profile
Roles
Ultragenyx Pharmaceutical
EVP & Chief Commercial Officer
Denali Therapeutics
Director
Address
Novato, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ultragenyx Pharmaceutical Inc.
3 Mar 23
4
Ultragenyx Pharmaceutical Inc.
22 Jun 22
4
Ultragenyx Pharmaceutical Inc.
3 Mar 22
3/A
Denali Therapeutics Inc.
14 Feb 22
4
Denali Therapeutics Inc.
7 Feb 22
3
Denali Therapeutics Inc.
7 Feb 22
4
Ultragenyx Pharmaceutical Inc.
18 Oct 21
4
Ultragenyx Pharmaceutical Inc.
8 Jul 21
4
Ultragenyx Pharmaceutical Inc.
23 Jun 21
4
Ultragenyx Pharmaceutical Inc.
10 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 45.25 | 3,664 | 165.80 k | 57,344 |
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 22,000 | 0.00 | 60,823 |
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 2,663 | 0.00 | 38,823 |
1 Mar 23 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 45.65 | 39,400 | 1.80 mm | 39,400 |
19 Jun 22 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 54.78 | 295 | 16.16 k | 36,160 |
1 Mar 22 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 14,000 | 0.00 | 36,317 |
1 Mar 22 | RARE Ultragenyx Pharmaceutical | Common Stock | Sell | Dispose S | No | No | 66.62 | 2,713 | 180.74 k | 22,317 |
1 Mar 22 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 67.37 | 24,900 | 1.68 mm | 24,900 |